Zostavax FDA Approval History
FDA Approved: Yes (Discontinued) (First approved May 25, 2006)
Brand name: Zostavax
Generic name: zoster vaccine live
Dosage form: Injection
Company: Merck & Co., Inc.
Treatment for: Herpes Zoster, Prophylaxis
Zostavax (zoster vaccine live) is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older.
- Zostavax is no longer available for use in the United States, as of November 18, 2020.
Development timeline for Zostavax
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.